Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $1.22 billion. The enterprise value is $1.16 billion.
| Market Cap | 1.22B |
| Enterprise Value | 1.16B |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 121.50 million shares outstanding. The number of shares has increased by 69.55% in one year.
| Current Share Class | 121.50M |
| Shares Outstanding | 121.50M |
| Shares Change (YoY) | +69.55% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 70.89% |
| Float | 107.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.88 |
| Forward PS | 8.68 |
| PB Ratio | 18.10 |
| P/TBV Ratio | 35.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 1.69.
| Current Ratio | 2.25 |
| Quick Ratio | 2.12 |
| Debt / Equity | 1.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -108.19 |
Financial Efficiency
Return on equity (ROE) is -471.16% and return on invested capital (ROIC) is -78.30%.
| Return on Equity (ROE) | -471.16% |
| Return on Assets (ROA) | -49.59% |
| Return on Invested Capital (ROIC) | -78.30% |
| Return on Capital Employed (ROCE) | -124.47% |
| Weighted Average Cost of Capital (WACC) | 6.05% |
| Revenue Per Employee | $858,098 |
| Profits Per Employee | -$1.99M |
| Employee Count | 102 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 6.07 |
Taxes
In the past 12 months, Verastem has paid $816,000 in taxes.
| Income Tax | 816,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.79% in the last 52 weeks. The beta is 0.39, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +25.79% |
| 50-Day Moving Average | 7.94 |
| 200-Day Moving Average | 6.12 |
| Relative Strength Index (RSI) | 66.67 |
| Average Volume (20 Days) | 5,650,367 |
Short Selling Information
The latest short interest is 14.96 million, so 12.32% of the outstanding shares have been sold short.
| Short Interest | 14.96M |
| Short Previous Month | 18.03M |
| Short % of Shares Out | 12.32% |
| Short % of Float | 13.96% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, Verastem had revenue of $87.53 million and -$202.70 million in losses. Loss per share was -$2.28.
| Revenue | 87.53M |
| Gross Profit | 76.71M |
| Operating Income | -159.80M |
| Pretax Income | -201.88M |
| Net Income | -202.70M |
| EBITDA | -158.65M |
| EBIT | -159.80M |
| Loss Per Share | -$2.28 |
Balance Sheet
The company has $136.35 million in cash and $84.33 million in debt, with a net cash position of $52.02 million or $0.43 per share.
| Cash & Cash Equivalents | 136.35M |
| Total Debt | 84.33M |
| Net Cash | 52.02M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 49.99M |
| Book Value Per Share | 0.55 |
| Working Capital | 98.03M |
Cash Flow
| Operating Cash Flow | -162.20M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.15M |
| Net Borrowing | -2.75M |
| Free Cash Flow | -162.20M |
| FCF Per Share | -$1.33 |
Margins
Gross margin is 87.64%, with operating and profit margins of -182.57% and -231.59%.
| Gross Margin | 87.64% |
| Operating Margin | -182.57% |
| Pretax Margin | -230.65% |
| Profit Margin | -231.59% |
| EBITDA Margin | -181.26% |
| EBIT Margin | -182.57% |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -69.55% |
| Shareholder Yield | -69.55% |
| Earnings Yield | -22.82% |
| FCF Yield | -13.35% |
Analyst Forecast
The average price target for Verastem is $17.22, which is 72.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.22 |
| Price Target Difference | 72.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 99.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -8.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.03 |
| Piotroski F-Score | 4 |